Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01159119 · ClinicalTrials.gov registry record · Phase 1
A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain
A Phase 1 study, sponsored by Forest Laboratories.
- Terminated
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01159119 is a Phase 1 study that was terminated before completion, run by Forest Laboratories. The registered enrollment target is 15 participants.
The verdict
NCT01159119, a Phase 1 study, was terminated before completion, sponsored by Forest Laboratories.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate two different treatments in subjects with chronic pancreatitis, exocrine pancreatic insufficiency and chronic abdominal pain.
Interventions
- DRUG EUR-1066-A
- DRUG Zenpep
- DRUG EUR-1066-B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-08-02 |
| Est. Completion | 2011-07-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01159119
The ClinicalTrials.gov registry entry for NCT01159119 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which EUR-1066-A is the first listed.
NCT01159119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01159119 about?
NCT01159119 is a clinical study titled "A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain". The purpose of this study is to evaluate two different treatments in subjects with chronic pancreatitis, exocrine pancreatic insufficiency and chronic abdominal pain.
What is the current status of trial NCT01159119?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2010-08-02. Estimated completion is 2011-07-01.
What interventions are being tested in trial NCT01159119?
The interventions under investigation include: EUR-1066-A (DRUG), Zenpep (DRUG), EUR-1066-B (DRUG).
Who is sponsoring clinical trial NCT01159119?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.